
Germany’s Fresenius Medical Care has announced a $1.7 billion merger agreement with US-based Liberty Dialysis Holdings, Inc., the holding company for Liberty Dialysis and Renal Advantage.
Liberty Dialysis has annual sales of approximately $1 billion and operates approximately 260 dialysis clinics, although Fresenius has said that some facilities may need to be divested to secure regulatory clearance.
The deal is expected to close in early 2012, and is expected to be accretive to earnings in the first year after closing of the transaction.